Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.
about
The contribution of the programmed cell death machinery in innate immune cells to lupus nephritis.Pharmacological modulation of cell death in organ transplantation.Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor Venetoclax.
P2860
Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.
@ast
Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.
@en
type
label
Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.
@ast
Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.
@en
prefLabel
Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.
@ast
Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.
@en
P2093
P2860
P50
P356
P1476
Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation
@en
P2093
Denisse Yanez
Jianing Wang
Junting Ai
Li Chun Wang
Lisa Olson
Marcus R Clark
Maryellen L Giger
Natalya Kaverina
P2860
P304
P356
10.1002/ART.39744
P577
2016-11-01T00:00:00Z